As a negative regulator of pathological angiogenesis, FOXP1 dysfunction would dysregulate angiogenic responses critical in diabetic retinopathy, leading to unopposed VEGF signaling and aberrant neovascularization characteristic of proliferative diabetic retinopathy (PDR) [41]. Here, FOXP1 is linked to proliferative diabetic retinopathy.